CCT6A, a novel prognostic biomarker for Ewing sarcoma.
Jie JiangChong LiuGuoyong XuTuo LiangChaojie YuShian LiaoZide ZhangZhaojun LuZequn WangJiarui ChenTianyou ChenHao LiXinli ZhanPublished in: Medicine (2021)
From the results of our study, we identified the expression levels of CCT6A to be strongly associated with prognosis of ES. Thus, the expression levels of the CCT6A gene could serve as a biomarker for the prediction of ES prognosis.